Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HETERO LABS LTD

  • FDA Approval
  • Sept. 10, 2024, 15:56 UTC
  • 50
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

WELDING

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 48
  • 0 comments

FDA approve CABERGOLINE

Comment Full text

ALVOGEN

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 55
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

AM REGENT

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 41
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text

CHENGDU SHUODE

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 41
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 53
  • 0 comments

FDA approve VERAPAMIL HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 46
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 37
  • 0 comments

FDA approve DESIPRAMINE HYDROCHLORIDE

Comment Full text

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 37
  • 0 comments

FDA approve DESIPRAMINE HYDROCHLORIDE

Comment Full text

MCPRF

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 52
  • 0 comments

FDA approve CHOLINE C-11

Comment Full text
  • Previous
  • 358
  • 359
  • 360
  • 361
  • 362
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158472)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin